R Modigliani Selected Research

Crohn Disease (Crohn's Disease)

1/2003	Corticosteroids for maintenance of remission in Crohn's disease.
6/2002	An open-label study of thalidomide for maintenance therapy in responders to infliximab in chronically active and fistulizing refractory Crohn's disease.
11/2001	[Infliximab therapy for Crohn's disease anoperineal lesions].
11/2001	Azathioprine for prevention of postoperative recurrence in Crohn's disease: a retrospective study.
5/2001	Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease.
2/2001	Use of anti-tumour necrosis factor agents in inflammatory bowel disease. European guidelines for 2001-2003.
1/2001	Corticosteroids for maintaining remission of Crohn's disease.
7/2000	Methotrexate in Crohn's disease: long-term efficacy and toxicity.
6/2000	Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy.
1/2000	Corticosteroids for maintaining remission of Crohn's disease.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

R Modigliani Research Topics

Disease

11	Crohn Disease (Crohn's Disease) 01/2003 - 01/2000
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 08/2000 - 07/2000
2	Leukopenia 06/2000 - 01/2000
1	Pathologic Constriction (Stenosis) 08/2003
1	Colitis 07/2003
1	Ulcerative Colitis 07/2003
1	Necrosis 06/2002
1	Ulcer 11/2001
1	Celiac Disease (Celiac Sprue) 07/2000
1	Thrombosis (Thrombus) 07/2000
1	Abscess 07/2000
1	Hyperhomocysteinemia 07/2000
1	Thiopurine S methyltranferase deficiency 06/2000
1	Thrombocytopenia (Thrombopenia) 06/2000
1	Pancreatitis 01/2000
1	Hypersensitivity (Allergy) 01/2000
1	Nausea 01/2000

Drug/Important Bio-Agent (IBA)

4	Infliximab (Remicade)FDA Link 07/2003 - 02/2001
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2003 - 01/2000
3	Azathioprine (Imuran)FDA LinkGeneric 11/2001 - 01/2000
2	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 06/2000 - 01/2000
1	AntimetabolitesIBA 07/2003
1	Thalidomide (Thalomid)FDA Link 06/2002
1	Monoclonal AntibodiesIBA 06/2002
1	N- (8- aminohexyl)- 5- iodonaphthalene- 1- sulfonamide (W8)IBA 11/2001
1	NF-kappa B (NF-kB)IBA 05/2001
1	Leucine (L-Leucine)FDA Link 05/2001
1	SteroidsIBA 08/2000
1	ParaffinIBA 07/2000
1	Methotrexate (Mexate)FDA LinkGeneric 07/2000
1	Folic Acid (Vitamin M)FDA LinkGeneric 07/2000
1	Complement System Proteins (Complement)IBA 07/2000
1	AntibodiesIBA 07/2000
1	thiopurine methyltransferase (thiopurine S-methyltransferase)IBA 06/2000

Therapy/Procedure

9	Therapeutics 08/2003 - 01/2000
1	Colonoscopes 08/2003
1	Intravenous Infusions 11/2001